Pharmaceutical Patent Term Extensions - recent developments

New Challenges and Opportunities Arising From Recent Developments in PTE, PTA and SPCs Around The World

Join world leading pharma/biopharma patent lawyers across three different time-zones for a 70 minute live webinar addressing recent developments in Patent Term Extensions (PTE), Patent Term Adjustments (PTA) and Supplementary Protection Certificates (SPC).

 Agenda

Offering perspectives from the United States, the United Kingdom, Europe and Australia, this seminar will address recent patent law developments, including:

• U & UK - Combination products: more questions of interpretation for the Court of Justice of the European Union to consider; SPC Manufacturing Waivers: when might pharma companies elect to seek a waiver under the new EU & UK regulations?
  Speakers: Charlotte Weekes and Ann Henry, Pinsent Masons
• US - PTA/PTE: Obviousness-type double patenting (ODP) and patent term; when might a terminal disclaimer cut short a PTA (in addition to a PTE)? 
  Speaker: Gaby Longsworth, Sterne Kessler
• AU – Why is PTE the hot topic in AU patent law? Is there any limit to the number and types of patents that can be extended in AU? Can I use a competitor product to obtain PTE?
  Speaker: Naomi Pearce, Pearce IP

Who should attend?

If you are a pharmaceutical/biopharmaceutical company operating globally and interested in understanding the regional nuances of PTE/PTA/SPC, this live webinar is not to be missed.